SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-050382
Filing Date
2018-09-21
Accepted
2018-09-21 16:25:22
Documents
5
Period of Report
2018-11-05
Effectiveness Date
2018-09-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv503174-def14a.htm DEF 14A 516282
2 GRAPHIC lg_phibrocorp-cmyk.jpg GRAPHIC 70242
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 13593
4 GRAPHIC tv503174_p1.jpg GRAPHIC 193897
5 GRAPHIC tv503174_p2.jpg GRAPHIC 125204
  Complete submission text file 0001144204-18-050382.txt   1072985
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 181081806
SIC: 2834 Pharmaceutical Preparations